Article
The common promoter polymorphism rs11666254 downregulates FPR2/ALX expression and increases risk of sepsis in patients with severe trauma.
Critical care (London, England) - 6 Jul 2017
Zhang Han, Lu Yao, Sun Guixiang, Teng Fang, Luo Nian, Jiang Jianxin, Wen Aiqing
Abstract excerpt
BACKGROUND: Formyl peptide receptor 2-lipoxin receptor (FPR2/ALX) modulates the anti-inflammatory response and therefore may be a target for treating sepsis. The purpose of this study was to investigate the association between genetic variants of the FPR2/ALX gene and sepsis after severe trauma as well as to further analyze the functions of sepsis-related genetic polymorphisms. METHODS: Three tag...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
